Back to results
US 2013/0022611 A1Published application
Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator
AssigneeGenentech, Inc.
InventorsDaniel K. Kirchhofer, Paul M. Moran
Life of this patent
Estimating the term…
Abstract
The invention provides methods and compositions for modulating hepsin activity and the uPA/plasmin pathway, in particular by regulating pro-uPA activation by hepsin.
Claims11
A method of identifying a candidate inhibitor substance that inhibits hepsin activation of pro-urokinase type plasminogen activator (pro-uPA), said method comprising:
- (a) contacting a candidate substance with a first sample comprising hepsin and a pro-uPA substrate, and (b) comparing amount of pro-uPA substrate activation in the sample with amount of pro-uPA substrate activation in a reference sample comprising similar amounts of hepsin and pro-uPA substrate as the first sample but that has not been contacted with said candidate substance, whereby a decrease in amount of pro-uPA substrate activation in the first sample compared to the reference sample indicates that the candidate substance is capable of inhibiting hepsin activation of single chain uPA (pro-uPA).
An antagonist molecule that inhibits interaction of hepsin and pro-uPA.
Dependencies are inferred from the claim text.